Morningstar analysts recommend these biotech stocks.
Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to develop one or two world-changing drugs or therapies for billion-dollar markets. The fates of these often volatile stocks are tied closely to study data and approval from the U.S. Food and Drug Administration or other global drug regulators. The biotech group has struggled as a whole in 2022, but the Morningstar analyst team says the innovation that has always supported the biotech industry is alive and well. Here are eight of Morningstar’s top biotech stocks to buy.